| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.26B | 5.09B | 4.77B | 4.30B | 3.83B |
| Gross Profit | 2.59B | 3.12B | 2.35B | 2.36B | 2.07B |
| EBITDA | 537.00M | 554.70M | -1.80M | 741.00M | 837.60M |
| Net Income | -666.70M | -452.70M | -928.60M | 24.20M | 249.30M |
Balance Sheet | |||||
| Total Assets | 9.40B | 10.14B | 10.85B | 8.74B | 7.25B |
| Cash, Cash Equivalents and Short-Term Investments | 554.10M | 390.60M | 400.60M | 658.50M | 487.10M |
| Total Debt | 3.99B | 3.96B | 3.63B | 3.39B | 2.58B |
| Total Liabilities | 8.07B | 8.12B | 8.06B | 5.42B | 4.08B |
| Stockholders Equity | 889.90M | 1.55B | 2.27B | 3.13B | 3.17B |
Cash Flow | |||||
| Free Cash Flow | 549.90M | 281.00M | 187.50M | 431.80M | 455.60M |
| Operating Cash Flow | 656.80M | 579.30M | 448.10M | 643.80M | 631.80M |
| Investing Cash Flow | -338.50M | -316.50M | -1.52B | -921.50M | -849.30M |
| Financing Cash Flow | -375.50M | -58.70M | 829.30M | 442.30M | -30.40M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | £88.00M | 14.08 | 22.77% | ― | 21.27% | 21.93% | |
65 Neutral | £426.74M | 6.26 | 9.03% | 2.58% | 8.26% | 263.36% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | £918.01M | 0.21 | 92.10% | 163.36% | ― | ― | |
55 Neutral | £3.55B | -7.35 | -57.07% | 2.24% | 5.14% | -7.80% | |
41 Neutral | £162.34M | -1.51 | 74.03% | ― | 5.26% | 32.20% |